BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28665088)

  • 1. A role for susceptibility weighted imaging in progressive multifocal leukoencephalopathy.
    Yap SM; Murray B; Lynch T; Kavanagh E; MacMahon P
    Ir Med J; 2017 Apr; 110(4):549. PubMed ID: 28665088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
    Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
    Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.
    Muto R; Sugita Y; Momosaki S; Ito Y; Wakugawa Y; Ohshima K
    Neuropathology; 2019 Feb; 39(1):58-63. PubMed ID: 30511425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
    Thurnher MM; Boban J; Rieger A; Gelpi E
    AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
    Paues J; Vrethem M
    J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.
    Carra-Dalliere C; Menjot de Champfleur N; Deverdun J; Ayrignac X; Nerrant E; Makinson A; Casanova ML; Labauge P
    J Neuroradiol; 2016 Feb; 43(1):6-10. PubMed ID: 26475668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
    Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
    J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
    Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
    J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy.
    López Sala P; Alberdi Aldasoro N; Zelaya Huerta MV; Bacaicoa Saralegui MC; Cabada Giadás T
    Radiologia (Engl Ed); 2020; 62(1):59-66. PubMed ID: 31375267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
    Alleg M; Solis M; Baloglu S; Cotton F; Kerschen P; Bourre B; Ahle G; Pruvo JP; Leclerc X; Vermersch P; Papeix C; Maillart É; Houillier C; Chabrot CM; Claise B; Malak S; Martin-Blondel G; Bonneville F; Caulier A; Marolleau JP; Bonnefoy JT; Agape P; Kennel C; Roussel X; Chauchet A; De Seze J; Fafi-Kremer S; Kremer S
    Eur Radiol; 2021 May; 31(5):2944-2955. PubMed ID: 33155106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Lesion in the Setting of Chronic Rituximab Treatment.
    Yazdani M; Antonucci M; Spampinato MV
    JAMA Oncol; 2020 Jul; 6(7):1093-1094. PubMed ID: 32463440
    [No Abstract]   [Full Text] [Related]  

  • 12. I saw the "shrimp sign": Cerebellar progressive multifocal leukoencephalopathy.
    Domit OCC; Corrêa DG
    Clin Imaging; 2024 Jul; 111():110171. PubMed ID: 38759601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report.
    Woo HH; Rezai AR; Knopp EA; Weiner HL; Miller DC; Kelly PJ
    Neurosurgery; 1996 Nov; 39(5):1031-4; discussion 1034-5. PubMed ID: 8905761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy.
    Colosimo C; Lebon P; Martelli M; Tumminelli F; Mandelli F
    Acta Neurol Belg; 1992; 92(1):24-9. PubMed ID: 1546522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.
    Godi C; De Vita E; Tombetti E; Davagnanam I; Haddow L; Jäger HR
    Eur Radiol; 2017 Sep; 27(9):3593-3599. PubMed ID: 28168372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
    Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
    Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.
    Sano Y; Nakano Y; Omoto M; Takao M; Ikeda E; Oga A; Nakamichi K; Saijo M; Maoka T; Sano H; Kawai M; Kanda T
    Intern Med; 2015; 54(8):965-70. PubMed ID: 25876582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.
    Mahajan KR; Amin M; Poturalski M; Lee J; Herman D; Zheng Y; Androjna C; Howell M; Fox RJ; Trapp BD; Jones SE; Nakamura K; Ontaneda D
    Mult Scler; 2021 Dec; 27(14):2159-2169. PubMed ID: 33749379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration.
    Ueno H; Kikumto M; Takebayashi Y; Ishibashi H; Takahashi T; Yasutomi H; Umemoto K; Nakamichi K; Saijo M; Ichinohe T; Maruyama H
    J Neurovirol; 2020 Jun; 26(3):452-455. PubMed ID: 32394398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-signal-intensity rim on susceptibility-weighted imaging is not a specific finding to progressive multifocal leukoencephalopathy.
    Umino M; Maeda M; Ii Y; Tomimoto H; Sakuma H
    J Neurol Sci; 2016 Mar; 362():155-9. PubMed ID: 26944139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.